When it comes to the subject of medical weed research, or even whether it’s okay for a vet and physician to discuss medicating with herb, the Department of Veterans Affairs has a tendency of ducking action in favor of citing hazy policy, and vague restrictions.
Department of Veterans Affairs Secretary David Shulkin took fire from lawmakers today over a lavish 10-day trip to Europe last year that cost taxpayers at least $122,000, detailed in a 97-page report by the VA’s Office of the Inspector General, published Feb. 14.
Proponents for research into using medical marijuana to treat post-traumatic stress disorder and chronic pain were dealt another blow this week, after comments from Department of Veterans Affairs Secretary David Shulkin made it clear the agency will not explore how the drug could help veterans.
The Department of Veterans Affairs will not conduct research into the effects of medical cannabis on post-traumatic stress disorder and chronic pain — some of the very ailments veteran patients rely on the drug to treat.
The House Committee on Veterans’ Affairs on Thursday initiated what could be a long and politically arduous process to get rid of aging and underused Department of Veterans Affairs facilities nationwide.